Clinical Trials Sponsored by Corpometria Institute

Total 74311 results

National Cancer Institute (NCI)

Completed

Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)

Renal Cell Carcinoma

United States
National Cancer Institute (NCI)

Completed

AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer

Breast Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer

Carcinoma, Non-Small Cell Lung | Carcinoma, Small-Cell Lung

United States
National Cancer Institute (NCI)

Completed

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

Peritoneal Carcinomatosis | Adrenocortical Carcinoma

United States
National Cancer Institute (NCI)

Completed

Intensity Modulated Radiation Therapy for Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Withdrawn

IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir

Hepatitis C Virus
National Cancer Institute (NCI)

Withdrawn

The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs

Cancer
National Cancer Institute (NCI)

Terminated

T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive

Melanoma | Cervical Cancer | Breast Cancer | Bladder Cancer | Renal Cancer

United States
National Cancer Institute (NCI)

Terminated

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Lung Neoplasms

United States
Institute for Neurodegenerative Disorders
National Institutes of Health (NIH); Molecular NeuroImaging

Completed

Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

Parkinson's Disease | Parkinsonian Syndrome
National Eye Institute (NEI)

Terminated

Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate (MEXX)

Non-infectious Intermediate and Posterior Uveitis

United States
National Cancer Institute (NCI)

Terminated

Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer

Renal Cancer | Birt-Hogg-Dube Syndrome

United States
National Cancer Institute (NCI)

Terminated

111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer

Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Completed

Sorafenib and TRC105 in Hepatocellular Cancer

Carcinoma, Hepatocellular | Liver Neoplasms | Hepatoma | Adenoma, Liver Cell | Liver Neoplasms, Experimental

United States
National Cancer Institute (NCI)

Completed

Clobetasol for Oral Graft-Versus-Host Disease

Oral Chronic Graft vs Host Disease

United States
National Cancer Institute (NCI)

Completed

Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer

Neoplasm Metastasis | Breast Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

Renal Cell Carcinoma | Breast Cancer | Lung Cancer | Non-Hodgkin Lymphoma | Colon Cancer

United States
National Cancer Institute (NCI)

Terminated

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Medullary Thyroid Carcinoma

United States
National Cancer Institute (NCI)

Terminated

Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy

Esophageal Cancer | Esophageal Neoplasms | Esophageal Adenocarcinoma | Squamous Cell Carcinoma | Esophageal Squamous Cell Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

Small Cell Lung Carcinoma | Malignant Epithelial Neoplasms | Carcinoma Neuroendocrine

United States
National Cancer Institute (NCI)

Completed

Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

Prostatic Neoplasms | Prostate Cancer | Neoplasms, Prostate

United States
National Cancer Institute (NCI)

Completed

A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

Metastatic Prostate Cancer

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Terminated

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Cancer
National Cancer Institute (NCI)

Completed

Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other

Ego | Cancer Prevention | Social Science

United States
National Cancer Institute (NCI)

Completed

Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses

Normal Physiology

United States
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Terminated

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISECONTROL)

Hematoma

Canada, Brazil
National Cancer Institute (NCI)

Terminated

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

Mesothelioma

United States
National Institutes of Health Clinical Center (CC)
National Eye Institute (NEI)

Terminated

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema (MIME)

Uveitis

United States
National Eye Institute (NEI)

Completed

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

Eye Diseases

United States
National Cancer Institute (NCI)

Withdrawn

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Melanoma | Sarcoma | Neoplasms, Germ Cell and Embryonal | Neoplasm Metastasis
National Cancer Institute (NCI)

Completed

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

Chronic Lymphocytic Leukemia

United States
National Cancer Institute (NCI)

Completed

AT13387 in Adults With Refractory Solid Tumors

Breast Cancer | Solid Tumors

United States
National Cancer Institute (NCI)

Completed

Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
National Eye Institute (NEI)

Completed

Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors

Solid Tumors | Brain Tumors | Brain Metastases

United States
National Cancer Institute (NCI)

Completed

Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer

Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Study of Diets and Way of Life of Native Americans and Hispanics in New Mexico During the Time of the Trinity Nuclear Test

Diet | Lifestyle | Ionizing Radiation Exposure

United States
National Cancer Institute (NCI)

Completed

A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)

Prostate Cancer | Metastatic Castrate Resistant Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin

Thyroid Neoplasm

United States
National Cancer Institute (NCI)

Terminated

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemias | Multiple Myeloma With Plasmacytoma

United States
National Cancer Institute (NCI)

Completed

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Neurofibromatosis 1 | Neurofibroma, Plexiform

United States
National Cancer Institute (NCI)

Completed

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Renal Cell Carcinoma

United States
National Cancer Institute (NCI)

Completed

Montelukast to Treat Bronchiolitis Obliterans

Chronic Graft Versus Host Disease | Stem Cell Transplant | Bronchiolitis Obliterans | Leukotriene | Montelukast

United States
National Cancer Institute (NCI)

Completed

Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients

Multiple Endocrine Neoplasia Type 2 | Medullary Thyroid Carcinoma

United States
National Cancer Institute (NCI)

Completed

Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta

Cervical Intraepithelial Neoplasia

United States
National Cancer Institute (NCI)

Completed

Self-Affirmation, Emotion, and Alcohol Consumption

Risk Reduction Behavior

United States
National Cancer Institute (NCI)

Completed

Genetic Analysis of Psoriasis and Psoriatic Arthritis

Psoriasis

United States
National Cancer Institute (NCI)

Completed

Breath Test for Chemicals (Volatile Organic Compounds)

Human Volunteers | Pilot Study | Breath Tests

United States
National Cancer Institute (NCI)

Terminated

Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas

Neoplasms

United States

Clinical Trials Sponsored by Corpometria Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations